Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR .ALPHA.) (HUMAN MONOCLONAL 3G3 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 3G3 .KAPPA.-CHAIN, DIMER

Non-Small Cell Lung Cancer

Eli Lilly and Companymonoclonal_antibodyPhase 2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
59/ 100

Competitive context

1206 Active assets in the Non-Small Cell Lung Cancer cohort.

Asset / SponsorPhaseRating
Zorifertinib
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3BBB
Necitumumab
Jonsson Comprehensive Cancer Center
Phase 3BBB
Glumetinib
Shanghai JMT-Bio Inc.
Phase 3BBB
Icotinib
The First Affiliated Hospital of Guangzhou Medical University
Phase 4BBB
d-0316
Betta Pharmaceuticals Co., Ltd.
Phase 2/3BBB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR .ALPHA.) (HUMAN MONOCLONAL 3G3 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 3G3 .KAPPA.-CHAIN, DIMER is also rated in:

adult glioblastomaDormant
B
Indicative ·
57 / 100
View asset →
ovarian neoplasmDormant
CCC
Indicative ·
54 / 100
View asset →
neoplasmDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →